Home RIGImmune

RIGImmune

In operation
Equity Financing
Developer of RNA Virus Treatment Methods
Basic
Enterprise Profile

Basic Information

RIGImmune is a biopharmaceutical research company co-founded by two renowned professors from Yale University, focusing on developing novel treatments for RNA viruses.
RIGImmune Inc.
Connecticut,United States of America
unclear
February 14, 2020
--
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Antibacterial/Antiviral Technology
Concept
Infectious Diseases Department Infectious Diseases Therapeutic Products
Application Scenarios
Biologics Innovative Drugs